Skip to main content

Medications for Neutropenia Associated with Chemotherapy

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
filgrastim 10 4 reviews for filgrastim to treat Neutropenia Associated with Chemotherapy
Rx C N
Generic name:
filgrastim systemic
Brand names:
Neupogen, Zarxio, Nivestym, Releuko
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Neupogen 10 1 review for Neupogen to treat Neutropenia Associated with Chemotherapy
Rx C N
Generic name:
filgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Zarxio 10 2 reviews for Zarxio to treat Neutropenia Associated with Chemotherapy
Rx C N
Generic name:
filgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
eflapegrastim 6.0 1 review for eflapegrastim to treat Neutropenia Associated with Chemotherapy
Rx N
Generic name:
eflapegrastim systemic
Brand name:
Rolvedon
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Neulasta 5.4 69 reviews for Neulasta to treat Neutropenia Associated with Chemotherapy
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
pegfilgrastim 5.1 74 reviews for pegfilgrastim to treat Neutropenia Associated with Chemotherapy
Rx C N
Generic name:
pegfilgrastim systemic
Brand names:
Neulasta, Udenyca, Fulphila, Ziextenzo, Fylnetra, Nyvepria, Stimufend
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Udenyca 1.0 3 reviews for Udenyca to treat Neutropenia Associated with Chemotherapy
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
efbemalenograstim alfa Rate Add review
Rx N
Generic name:
efbemalenograstim alfa systemic
Brand name:
Ryzneuta
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Fulphila Rate Add review
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Fylnetra Rate Add review
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Granix Rate Add review
Rx C N
Generic name:
tbo-filgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
Leukine Rate Add review
Rx C N
Generic name:
sargramostim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Nivestym Rate Add review
Rx C N
Generic name:
filgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Nyvepria Rate Add review
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Releuko Rate Add review
Rx C N
Generic name:
filgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Rolvedon Rate Add review
Rx N
Generic name:
eflapegrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Ryzneuta Rate Add review
Rx N
Generic name:
efbemalenograstim alfa systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
sargramostim Rate Add review
Rx C N
Generic name:
sargramostim systemic
Brand name:
Leukine
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Stimufend Rate Add review
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
tbo-filgrastim Rate Add review
Rx C N
Generic name:
tbo-filgrastim systemic
Brand name:
Granix
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
Ziextenzo Rate Add review
Rx C N
Generic name:
pegfilgrastim systemic
Drug class:
colony stimulating factors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.